Nascentia Health At Home | |
1050 West Genesee Street, Syracuse, New York 13204 | |
(315) 476-3101 | |
Name | Nascentia Health At Home |
---|---|
Location | 1050 West Genesee Street, Syracuse, New York |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 337052 |
Ownership Type | Voluntary Non-profit - Private |
Service Area Zip Codes | 13021, 13027, 13028, 13029, 13030, 13031, 13032, 13033, 13036, 13039, 13041, 13042, 13044, 13051, 13054, 13057, 13060, 13063, 13066, 13069, 13074, 13076, 13077, 13078, 13080, 13082, 13083, 13084, 13088, 13090, 13104, 13108, 13110, 13112, 13114, 13115, 13116, 13117, 13118, 13119, 13120, 13121, 13123, 13126, 13131, 13132, 13135, 13138, 13140, 13142, 13144, 13145, 13152, 13157, 13159, 13160, 13162, 13164, 13166, 13167, 13202, 13203, 13204, 13205, 13206, 13207, 13208, 13209, 13210, 13211, 13212, 13214, 13215, 13219, 13224, 13302, 13303, 13304, 13308, 13309, 13313, 13316, 13318, 13319, 13321, 13322, 13323, 13338, 13354, 13357, 13363, 13403, 13413, 13417, 13421, 13424, 13425, 13431, 13437, 13438, 13440, 13455, 13456, 13461, 13469, 13471, 13476, 13477, 13478, 13479, 13480, 13486, 13490, 13492, 13493, 13494, 13495, 13501, 13502, 14589 |
NPI Number | 1265437982 |
Organization Name | VISITING NURSE ASSOCIATION OF CENTRAL NEW YORK, INC. |
Address | 1050 W Genesee St, Syracuse, NY 13204 |
Phone Number | 315-476-3101 |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
NPI Number | 1447244660 |
Organization Name | INDEPENDENT HEALTH CARE SERVICES,INC. |
Address | 1050 W Genesee St, Syracuse, NY 13204 |
Phone Number | 315-424-3744 |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
NPI Number | 1467527283 |
Organization Name | HOME AIDES OF CENTRAL NEW YORK, INC. |
Address | 1050 West Genesee Street, Syracuse, NY 13204 |
Phone Number | 315-477-4663 |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
NPI Number | 1700870011 |
Organization Name | NASCENTIA COMMUNITY CARE |
Doing Business As | CCH HOME CARE & PALLIATIVE SERVICES, INC. |
Address | 1050 W Genesee St, Syracuse, NY 13204 |
Phone Number | 315-641-2385 |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
Quality Rating: |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 97.7 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.1 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.4 | 99.6 |
How often the home health team checked patients for depression | 98.2 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 75.4 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 86 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.2 | 96.4 |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 84.2 | 79.6 |
How often patients got better at getting in and out of bed | 85.3 | 81.1 |
How often patients got better at bathing | 85.7 | 82.3 |
How often patients’ breathing improved | 84 | 82.8 |
How often patients’ wounds improved or healed after an operation | 97.4 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 76 | 75 |
How often home health patients had to be admitted to the hospital | 14.6 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 16.1 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 95.8 | 94 |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
The patient survey data of Nascentia Health At Home is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 89 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 84 | 78 |
News Archive
A team of Northwestern University scientists will meet with Environmental Protection Agency (EPA) administrators in Washington D.C. Oct. 18 to advocate for important changes in the agency's guidelines for reproductive health research.
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are not a reliable measure for estimating the level of risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in schools.
The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
› Verified 7 days ago
Nascentia Health At Home Location: 1050 West Genesee Street, Syracuse, New York 13204 Ratings: Phone: (315) 476-3101 | |
St Camillus Home Care Agency Location: 813 Fay Rd, Syracuse, New York 13219 Ratings: Phone: (315) 488-2831 |